Pava Partners advised EMZ Partners on the acquisition of a majority stake in imes-icore Holding GmbH (“imes-icore” or “the Company”), a portfolio company of Ardian. Founder and CEO Christoph Stark, CFO/COO Christian Müller and other members of the management team will retain a significant stake in the company.

imes-icore currently offers the world’s most comprehensive portfolio of milling and grinding machines for the automated production of dental restorations. The Eiterfeld-based company was founded in 2002 by Christoph Stark and Hugo Isert and is a leading provider of CNC CAD/CAM systems for the dental industry. It designs, develops and manufactures dental milling systems and also offers a comprehensive portfolio of after-sales services, including materials, tools, milling services and competence and service centers. imes-icore is known worldwide for its first-class product range and the implementation of the highest quality standards.

The company employs 274 people at locations in Germany, the USA and South East Asia. With a global presence via an extensive network of distributors, the company serves all customer segments of the dental market such as dentists, dental clinics, dental laboratories and milling centers with a comprehensive product portfolio.

“We look forward to further developing imes-icore together with CEO Christoph Stark, CFO/COO Christian Müller and the rest of the management team. As a leading supplier of dental milling systems with a strong position in both the dental laboratory and dentist segments, imes-icore is well positioned to continue its sustainable growth course. We strongly believe in affordable, high-quality medical care and fully identify with imes-icore’s mission to provide its customers with efficient delivery of first-class dental prosthetics. As a partner to the management team and all other imes-icore stakeholders, we will actively support the company’s growth plans, says Klaus Maurer, Senior Partner at EMZ.

Christoph Stark, founder and CEO of imes-icore, adds: “With EMZ Partners as our new majority shareholder, we are gaining a strong partner who fully supports our vision and growth plans for imes-icore.

Klaus Maurer summarizes Pava Partners as follows: “Another successful collaboration with the Pava MedTech team. Added value is delivered here!”.

Completion of the transaction is still subject to approval by the relevant antitrust authorities. The parties have agreed not to disclose the financial details.